Russia’s new device regulatory system not always a smooth ride for medtech industry
This article was originally published in Clinica
Executive Summary
IMEDA chief executive Alexandra Tretiakova tells Clinica that device manufacturers are still finding out about the new regulatory system some 18 months after it was embarked upon